X4 Pharmaceuticals, Inc SC 13D and SC 13D/A reports

Location
61 North Beacon Street, 4 Th Floor, Boston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
6/28/2024, 01:20 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 May 26, 2023
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 Dec 20, 2022
SC 13D Report GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 Jul 19, 2022
SC 13D/A Report SC 13D/A Jul 17, 2019
SC 13D/A Report NEW ENTERPRISE ASSOCIATES 16, L.P. - X4 PHARMACEUTICALS, INC. 13D/A1 May 28, 2019
SC 13D/A Report SC 13D/A Apr 26, 2019
SC 13D Report SC 13D Mar 22, 2019
SC 13D/A Report AMENDMENT NO. 2 Mar 19, 2019
SC 13D Report SCHEDULE 13D Dec 6, 2018
SC 13D Report SC 13D Feb 14, 2018
SC 13D/A Report AMENDMENT NO. 1 Jan 26, 2018
SC 13D Report SCHEDULE 13D Nov 30, 2017
SC 13D Report SC 13D Nov 29, 2017
SC 13D Report NEW ENTERPRISE ASSOCIATES 16, L.P. - ARSANIS, INC. 13D Nov 29, 2017